David J. Arthur - Apr 11, 2024 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Chief Executive Officer, Director
Signature
/s/Mark Rosenblum, as Attorney-in-Fact
Stock symbol
SLRX
Transactions as of
Apr 11, 2024
Transactions value $
$0
Form type
4
Date filed
4/12/2024, 04:50 PM
Previous filing
Feb 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLRX Stock Option (right to buy) Award $0 +20.5K $0.00 20.5K Apr 11, 2024 Common Stock 20.5K $0.51 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.